Abstract:Abstract Tumor-infiltrated regulatory T-cells (Treg) restrict the function of effector T-cells and thereby promote tumor growth. Disrupting the immunosuppression of Treg cells presents an attractive strategy for cancer immunotherapy; However, the risk of autoimmunity, resulting from systemic Treg depletion, limits its therapeutic effectiveness. Here, we show that genetic depletion of Ube2n in Treg cells inhibits tumor growth which is correlated with a markedly enhanced infiltration of cytotoxic immune cells. Notably, the deletion of Ube2n in a fraction of Treg cells was sufficient to produce a long-lasting anti-tumor effect, without apparent systemic autoimmune responses. The antitumor effect persists following adoptive T-cell transfer to an otherwise immunodeficient mouse tumor model. Through flow cytometry, immunostaining and T-cell targeted single-cell sequencing analyses, we demonstrate that the loss of Ube2n dampens Treg suppressive function, as indicated by markedly increased numbers of cytotoxic CD8 T-cells in the tumor microenvironment (TME). Further, differentially expressed genes analyses show a downregulation of Mki67 and an upregulation of Ifng in Ube2n deficient Tregs, concomitant with amplification and activation of effector T-cells. Our findings uncover a hitherto unexplored role of Ube2n in orchestrating the differentiation and functions of Treg in TME, highlighting the therapeutic potential of targeting this pathway to enhance and reprogram anti-tumor immunity. Citation Format: Wanying Miao, Yingai J. Jin, Vaibhav Jain, Simon Gregory, Jennifer Y. Zhang. Targeting regulatory T cells to boost immunity against melanoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 2919.

Regulatory T Cells Nanoextinguisher to Manipulate Multiple Immune Evasion for Immunotherapy

Cancer Immunotherapies Targeting Tumor-Associated Regulatory T Cells

Tumor Microenvironment-Modulated Multiple Nanotherapeutic System for Potent Cancer Immunotherapy and Metastasis Inhibition

Local T Regulatory Cells Depletion by an Integrated Nanodrug System for Efficient Chem-Immunotherapy of Tumor

Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

How to Detour Treg Cells in T Cell-Based Antitumor Immune Therapy

Advance in the Study of CD4~+CD25~+FOXP3~+ Regulatory T Cell in Tumor Immune Evasion

Regulatory T Cells and Their Clinical Applications in Antitumor Immunotherapy

Regulatory T cells in tumor immunity

Antibody-based Cancer Immunotherapy by Targeting Regulatory T Cells

Immunotherapy of Cancer by Targeting Regulatory T cells

Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects

Spatiotemporal Nano‐Regulator Unleashes Anti‐Tumor Immunity by Overcoming Dendritic Cell Tolerance and T Cell Exhaustion in Tumor‐Draining Lymph Nodes

Redox Modulation with a Perfluorocarbon Nanoparticle to Reverse Treg-mediated Immunosuppression and Enhance Anti-Tumor Immunity

Abstract 2919: Targeting regulatory T cells to boost immunity against melanoma

Regulatory T Cell and Tumor Immunity

Transient Regulatory-T-cell Interruption Promotes Skin-Resident Memory T Cells Mediated Tumor Protection

Precise Spatiotemporal Interruption of Regulatory T-cell-Mediated CD8(+) T-cell Suppression Leads to Tumor Immunity

Overcoming T Cell Exhaustion in Tumor Microenvironment via Immune Checkpoint Modulation with Nano‐Delivery Systems for Enhanced Immunotherapy

Acquisition of suppressive function by conventional T cells limits antitumor immunity upon Treg depletion

Nano-engineered Lymphocytes for Alleviating Suppressive Tumor Immune Microenvironment